Pfizer to abandon $160 billion merger with Allergan

The move follows a crackdown by the US government on corporate inversions

6th April, 2016
Pfizer is to abandon its proposed merger with AstraZeneca Pic: Getty

Pfizer decided to terminate its $160 billion (€140 billion) merger with Allergan, a person familiar with the matter said, marking an end to the largest-ever health-care acquisition as officials in Washington crack down on corporate inversions.

Pfizer will need to pay a $400 million fee to Allergan for expenses relating to the deal, the person said, asking not to be identified as the information is private. Allergan, which is run from New Jersey but has...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Edel Coffey: The long, slow liberation of getting old

Columnists Edel Coffey 20 hours ago

Nadine O’Regan: What is it that we do in nightclubs again?

Elaine Byrne: Establishing the truth about the 3,269 murders of the Troubles will always be in the public interest

The Last Post: It seems that the temporary rise in inflation is likely to become permanent

The Last Post Matt Cooper 20 hours ago